Analystreport

Moleculin Biotech Inc (NASDAQ: MBRX) is now covered by analysts at Maxim Group. They set a "buy" rating and a $3.00 price target on the stock.

Moleculin Biotech, Inc.  (MBRX) 
Last moleculin biotech, inc. earnings: 8/16 05:35 pm Check Earnings Report
US:NASDAQ Investor Relations: moleculin.com/investors